Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 15,137 | 3,936 | 4,525 | 1,802 | 1,922 |
| Operating Income | -15,137 | -3,936 | -4,525 | -1,802 | -1,922 |
| Interest Expense | 281 | 37 | 161 | 59 | 0 |
| Other Income | 3 | 12 | 18 | 5 | 4 |
| Pre-tax Income | -15,415 | -3,961 | -4,668 | -1,856 | -1,917 |
| Income Tax | -1,001 | -603 | -903 | N/A | N/A |
| Net Income Continuous | -14,414 | -3,358 | -3,765 | -1,856 | -1,917 |
| Net Income | $-14,414 | $-3,358 | $-3,765 | $-1,856 | $-1,917 |
| EPS Basic Total Ops | -1,270.00 | -350.00 | -355.00 | -210.08 | -245.10 |
| EPS Basic Continuous Ops | -960.92 | -303.83 | -353.06 | -199.40 | -228.93 |
| EPS Diluted Total Ops | -1,270.00 | -350.00 | -355.00 | -210.08 | -245.10 |
| EPS Diluted Continuous Ops | -960.92 | -303.83 | -353.06 | -199.40 | -228.93 |
| EPS Diluted Before Non-Recurring Items | -690.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-14,333 | $-3,130 | $-4,517 | $-1,777 | $-1,920 |